Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-3,035
Closed -$523K 72
2017
Q2
$523K Sell
3,035
-600
-17% -$97.6K 0.33% 51
2017
Q1
$596K Sell
3,635
-290
-7% -$48.2K 0.37% 48
2016
Q4
$574K Buy
3,925
+150
+4% +$22.6K 0.35% 50
2016
Q3
$630K Sell
3,775
-25
-0.7% -$4.23K 0.38% 47
2016
Q2
$578K Hold
3,800
0.35% 50
2016
Q1
$570K Sell
3,800
-25
-0.7% -$3.71K 0.37% 46
2015
Q4
$621K Sell
3,825
-100
-3% -$15.7K 0.42% 43
2015
Q3
$543K Buy
3,925
+161
+4% +$25.4K 0.38% 44
2015
Q2
$578K Buy
3,764
+70
+2% +$11.2K 0.37% 44
2015
Q1
$590K Sell
3,694
-14
-0.4% -$2.21K 0.36% 41
2014
Q4
$591K Sell
3,708
-167
-4% -$26K 0.36% 44
2014
Q3
$544K Hold
3,875
0.36% 44
2014
Q2
$459K Sell
3,875
-100
-3% -$11.6K 0.3% 46
2014
Q1
$490K Sell
3,975
-2,450
-38% -$297K 0.34% 43
2013
Q4
$733K Hold
6,425
0.52% 36
2013
Q3
$719K Sell
6,425
-175
-3% -$19K 0.54% 38
2013
Q2
$651K Buy
+6,600
New +$685K 0.48% 37

Other funds holding AMGN

Lawrence B. Cohen's AMGN Position: Q3 2017 in Review

Lawrence B. Cohen sold out of Amgen (AMGN) in Q3 2017, closing a stake of 3,035 shares — an estimated $523K sold.

Lawrence B. Cohen first reported a position in AMGN in Q2 2013 and held it in 17 quarters. The position peaked at $733K in Q4 2013. 1,605 funds tracked by Wall St. Rank hold AMGN as of Q3 2017.

  • Lawrence B. Cohen reported no remaining Amgen position as of Q3 2017 after selling out during the quarter.
  • Lawrence B. Cohen sold 3,035 Amgen shares in Q3 2017, an estimated $523K.
  • Lawrence B. Cohen first reported a position in Amgen in Q2 2013 and held it in 17 quarters.
  • Lawrence B. Cohen's Amgen position peaked at $733K in Q4 2013.
  • 1,605 funds tracked by Wall St. Rank held Amgen as of Q3 2017.

Based on Lawrence B. Cohen's 13F filing for Q3 2017, filed 3 Nov 2017.